David Domzalski - 30 Jun 2023 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
President and CEO, Director
Signature
/s/ Mutya Harsch, attorney-in-fact for David Domzalski
Issuer symbol
VYNE
Transactions as of
30 Jun 2023
Net transactions value
-$4,022
Form type
4
Filing time
05 Jul 2023, 16:30:41 UTC
Previous filing
02 Jun 2023
Next filing
04 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability $4,022 -981 -1.8% $4.10 52,433 30 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.